Accéder directement au contenu Accéder directement à la navigation
Nouvelle interface
Article dans une revue

Inhibiting homologous recombination by targeting RAD51 protein

Abstract : Homologous recombination (HR) is involved in repairing DNA double-strand breaks (DSB), the most harmful for the cell. Regulating HR is essential for maintaining genomic stability. In many forms of cancer, overactivation of HR increases tumor resistance to DNA-damaging treatments. RAD51, HR's core protein, is very often over- expressed in these cancers and plays a critical role in cancer cell development and survival. Targeting RAD51 directly to reduce its activity and its expression is therefore one strategy to sensitize and overcome resistance cancer cells to existing DNA-damaging therapies which remains the limiting factor for the success of targeted therapy. This review describes the structure and biological roles of RAD51, summarizes the different targeted sites of RAD51 and its inhibitory compounds discovered and described in the last decade.
Liste complète des métadonnées
Contributeur : Benoît Chénais Connectez-vous pour contacter le contributeur
Soumis le : vendredi 17 septembre 2021 - 11:23:46
Dernière modification le : mercredi 27 avril 2022 - 04:05:02



A. Demeyer, H. Benhelli-Mokrani, Benoît Chénais, P. Weigel, F. Fleury. Inhibiting homologous recombination by targeting RAD51 protein. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1876 (2), pp.188597. ⟨10.1016/j.bbcan.2021.188597⟩. ⟨hal-03347460⟩



Consultations de la notice